Moreover, the STA assay complements tau-PET imaging, which largely detects fibrillar tau in later Braak phases. By capturing early soluble aggregates, this assay could refine client stratification in clinical trials, ensuring that those liable to developing symptomatic AD are recognized sooner.They then seeded these mobile lines with fibrils from e